Lustgarten Foundation for Pancreatic Cancer Research
Tracked across 1 events · 21 articles · First seen Jul 16, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A phase 1 clinical trial of mKRAS-VAX, an investigational vaccine targeting six common KRAS mutations, demonstrated safety and durable immune responses in 18 of 20 high-risk individuals for pancreatic ductal adenocarcinoma (PDAC). The vaccine, developed…
Impact: Co-funder of the study; positive results validate its investment in pancreatic cancer research.
Jul 16, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Lustgarten Foundation for Pancreatic Cancer Research live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard